Publications

Found 127 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Agemy L, Kotamraju VR, Friedmann-Morvinski D, Sharma S, Sugahara KN, Ruoslahti E.  2013.  Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. Molecular Therapy. 21:2195–2204.
B Ahn K, Das S, Linstadt R, Kaufman Y, Martinez-Rodriguez NR, Mirshafian R, Kesselman E, Talmon Y, Lipshutz BH, Israelachvili JN et al..  2015.  High-performance mussel-inspired adhesives of reduced complexity. Nature communications. 6
Alberici L, Roth L, Sugahara KN, Agemy L, Kotamraju VR, Teesalu T, Bordignon C, Traversari C, Rizzardi G-P, Ruoslahti E.  2013.  De novo design of a tumor-penetrating peptide. Cancer research. 73:804–812.
Anselmo AC, Gilbert JB, Kumar S, Gupta V, Cohen RE, Rubner MF, Mitragotri S.  2014.  Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. Journal of Controlled Release.
Anselmo AC, Gupta V, Zern BJ, Pan D, Zakrewsky M, Muzykantov V, Mitragotri S.  2013.  Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells. ACS nano. 7:11129–11137.
Anselmo AC, Modery-Pawlowski CLynn, Menegatti S, Kumar S, Vogus DR, Tian LL, Chen M, Squires TM, Gupta ASen, Mitragotri S.  2014.  Platelet-like Nanoparticles (PLNs): Engineering Shape, Flexibility and Surface Chemistry of Nanocarriers to Target Vascular Injuries. ACS nano.
Azarenko O, Smiyun G, Mah J, Wilson L, Jordan MAnn.  2014.  Antiproliferative Mechanism of Action of the Novel Taxane Cabazitaxel as Compared with the Parent Compound Docetaxel in MCF7 Breast Cancer Cells. American Association for Cancer Research. 13:2092–2103.
B
Bailey JK, Fields AT, Cheng K, Lee A, Wagenaar E, Lagrois R, Schmidt B, Xia B, Ma D.  2015.  WD Repeat-Containing Protein 5 (WDR5) Localizes to the Midbody and Regulates Abscission. Journal of Biological Chemistry. :jbc–M114.
Barua S, Mitragotri S.  2014.  Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects. Nano Today.
Barua S, Yoo J-W, Kolhar P, Wakankar A, Gokarn YR, Mitragotri S.  2013.  Particle shape enhances specificity of antibody-displaying nanoparticles. Proceedings of the National Academy of Sciences. 110:3270–3275.
Benbow SJ, Wozniak KM, Kulesh B, Savage A, Slusher BS, Littlefield BA, Jordan MAnn, Wilson L, Feinstein SC.  2017.  Microtubule-Targeting Agents Eribulin and Paclitaxel Differentially Affect Neuronal Cell Bodies in Chemotherapy-Induced Peripheral Neuropathy. Neurotoxicity Research. :1–12.
Benbow SJ, Cook BM, Reifert J, Wozniak KM, Slusher BS, Littlefield BA, Wilson L, Jordan MAnn, Feinstein SC.  2016.  Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy. Neurotoxicity Research. 29:299–313.
Bonham AJ, Wenta N, Osslund LM, Prussin AJ, Vinkemeier U, Reich NO.  2013.  STAT1: DNA sequence-dependent binding modulation by phosphorylation, protein: protein interactions and small-molecule inhibition. Nucleic acids research. 41:754–763.
Braden BP, Taketa DA, Pierce JD, Kassmer S, Lewis DD, De Tomaso AW.  2014.  Vascular Regeneration in a Basal Chordate Is Due to the Presence of Immobile, Bi-Functional Cells. PloS one. 9:e95460.
Braun GB, Friman T, Pang H-B, Pallaoro A, de Mendoza THurtado, Willmore A-MA, Kotamraju VRamana, Mann AP, She Z-G, Sugahara KN et al..  2014.  Etchable plasmonic nanoparticle probes to image and quantify cellular internalization. Nature materials.
Brunquell C, Biliran H, Jennings S, Ireland SKale, Chen R, Ruoslahti E.  2012.  TLE1 Is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. Molecular Cancer Research. 10:1482–1495.
C
Cai D, Dai W, Prasad M, Luo J, Gov NS, Montell DJ.  2016.  Modeling and analysis of collective cell migration in an in vivo three-dimensional environment. Proceedings of the National Academy of Sciences.
Camacho KM, Kumar S, Menegatti S, Vogus DR, Anselmo AC, Mitragotri S.  2015.  Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid. Journal of Controlled Release. 210:198-207.
Camacho KM, Menegatti S, Vogus DR, Pusuluri A, Fuchs Z, Jarvis M, Zakrewsky M, Evans MA, Chen R, Mitragotri S.  2016.  DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy. Journal of Controlled Release. 229:154-162.
Camacho KM, Menegatti S, Mitragotri S.  2016.  Low-molecular-weight polymer–drug conjugates for synergistic anticancer activity of camptothecin and doxorubicin combinations. Nanomedicine. 11(9)
Catania C, Thomas AW, Bazan GC.  2016.  Tuning cell surface charge in E. coli with conjugated oligoelectrolytes. Chem. Sci.. 7:2023-2029.
Chen R, Braun GB, Luo X, Sugahara KN, Teesalu T, Ruoslahti E.  2013.  Application of a proapoptotic peptide to intratumorally spreading cancer therapy. Cancer research. 73:1352–1361.
Chen M, Gupta V, Anselmo AC, Muraski JA, Mitragotri S.  2014.  Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers. Journal of Controlled Release. 173:67–74.
Chen M, Kumar S, Anselmo AC, Gupta V, Slee DH, Muraski JA, Mitragotri S.  2014.  Topical delivery of Cyclosporine A into the skin using SPACE-peptide. Journal of Controlled Release.
Chen M, Zakrewsky M, Gupta V, Anselmo AC, Slee DH, Muraski JA, Mitragotri S.  2014.  Topical delivery of siRNA into skin using SPACE-peptide carriers. Journal of Controlled Release. 179:33–41.

Pages